Renal Cancer
Evaluating Trials of Adjuvant Therapy: Is There Benefit for People With Resected Renal Cancer?
March 21, 2024
Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence?
March 21, 2024
Cytoreductive nephrectomy in the era of immune checkpoint inhibitors: a U.S. FDA pooled analysis.
March 20, 2024
Integrative Analysis of Germline Rare Variants in Clear and Non-clear Cell Renal Cell Carcinoma.
March 19, 2024
Prognostic factors of renal cell cancer in elderly patients: a population-based cohort study.
March 18, 2024
A contemporary comparison of laparoscopic versus open partial nephrectomy for renal cell carcinoma.
March 14, 2024
A network meta-analysis evaluating the efficacy and safety of adjuvant therapy after nephrectomy in renal cell carcinoma.
March 14, 2024
The Prevalence and Radiologic Features of Renal Cancers Associated with FLCN, BAP1, SDH, and MET Germline Mutations.
March 12, 2024
Dose-response of localized renal cell carcinoma after stereotactic body radiation therapy: A meta-analysis.
March 12, 2024